Replication and characterisation of genetic variants in the fibrinogen gene cluster with plasma fibrinogen levels and haematological traits in the Third National Health and Nutrition Examination Survey

Thrombosis and Haemostasis

Volumn 107, Issue 3, 2012, Pages 458-467

  Jeff, Janina M ^a   Brown Gentry, Kristin ^a   Crawford, Dana C ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fibrinogen; Pleiotropy; Replication

Indexed keywords

FIBRINOGEN; FIBRINOGEN VARIANT; TRIACYLGLYCEROL;

ADULT; ARTICLE; BIOLOGICAL TRAIT; CROSS-SECTIONAL STUDY; FEMALE; FIBRINOGEN GENE CLUSTER; GENE CLUSTER; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEALTH SURVEY; HEMATOLOGICAL TRAIT; HUMAN; LEUKOCYTE COUNT; MALE; NORMAL HUMAN; PLATELET DISTRIBUTION WIDTH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FIBRINOGEN; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; HEALTH SURVEYS; HUMANS; MALE; MEXICAN AMERICANS; MIDDLE AGED; MULTIGENE FAMILY; NUTRITION SURVEYS; QUANTITATIVE TRAIT, HERITABLE; TRIGLYCERIDES; UNITED STATES; YOUNG ADULT;

EID: 84857746211     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-07-0497     Document Type: Article

References (45)

1. Pennington J, Garner SF, Sutherland J, et al. Residual subset population analysis in WBC-reduced blood components using real-time PCR quantitation of specific mRNA. Transfusion 2001; 41: 1591-1600.
2. Evans DM, Frazer IH, Martin NG. Genetic and environmental causes of variation in basal levels of blood cells. Twin Res 1999; 2: 250-257.
3. Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-537.
4. Tosetto A, Prati P, Baracchini C, et al. Association of plasma fibrinogen, C-reactive protein and G-455>A polymorphism with early atherosclerosis in the VITA Project cohort. Thromb Haemost 2011; 105: 329-335.
5. Boos CJ, Lip GY. Platelet activation and cardiovascular outcomes in acute coronary syndromes. J Thromb Haemost 2006; 4: 2542-2543.
6. Danesh J, Lewington S. Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies. J Cardiovasc Risk 1998; 5: 229-232.
7. Ensrud K, Grimm RH, Jr. The white blood cell count and risk for coronary heart disease. Am Heart J 1992; 124: 207-213.
8. Kannel WB, Wolf PA, Castelli WP, et al. Fibrinogen and risk of cardiovascular disease. The Framingham Study. J Am Med Assoc 1987; 258: 1183-1186.
9. Collet JP, Soria J, Mirshahi M, et al. Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure. Blood 1993; 82: 2462-2469.
10. Voetsch B, Loscalzo.J. Genetic Determinants of Arterial Thrombosis. Arterioscler Thromb Vasc Biol 2003; 24: 216-229.
11. Siegerink B, Rosendaal FR, Algra A. Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke. J Thromb Haemost 2009; 7: 385-390.
12. Boekholdt SM, Bijsterveld NR, Moons AH, et al. Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation 2001; 104: 3063-3068.
13. Folsom AR, Aleksic N, Ahn C, et al. Beta-fibrinogen gene-455G/A polymorphism and coronary heart disease incidence: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 2001; 11: 166-170.
14. Koch W, Hoppmann P, Biele J, et al. Fibrinogen genes and myocardial infarction: a haplotype analysis. Arterioscler Thromb Vasc Biol 2008; 28: 758-763.
15. Hamsten A, Iselius L, de Faire U, et al. Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet 1987; 2: 988-991.
16. Meisinger C, Prokisch H, Gieger C, et al. A genome-wide association study identifies three loci associated with mean platelet volume. Am J Hum Genet 2009; 84: 66-71.
17. Soranzo N, Spector TD, Mangino M, et al. A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet 2009; 41: 1182-1190.
18. Margaglione M, Grandone E. Population genetics of venous thromboembolism. A narrative review. Thromb Haemost 2011; 105: 221-231.
19. Rosendaal FR, Doggen CJ, Zivelin A, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998; 79: 706-708.
20. Grody WW, Griffin JH, Taylor AK, et al. American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med 2001; 3: 139-148.
21. Grody WW. Molecular genetic risk screening. Annu Rev Med 2003; 54: 473-490.
22. McGlennen RC, Key NS. Clinical and laboratory management of the prothrombin G20210A mutation. Arch Pathol Lab Med 2002; 126: 1319-1325.
23. Crawford DC, Sanders CL, Qin X, et al. Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation 2006; 114: 2458-2465.
24. Chang MH, Lindegren ML, Butler MA, et al. Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. Am J Epidemiol 2009; 169: 54-66.
25. Steinberg KK, Sanderlin KC, Ou CY, et al. DNA banking in epidemiologic studies. Epidemiol Rev 1997; 19: 156-162.
26. Centers for Disease Control and Prevention Third National Health and Nutrition Examination Survey, 1988-94, Plan and Operations Procedures Manual. 1996.
27. Centers for Disease Control and Prevention Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-94. Bethesda, MD; 2004.
28. Gunter EW, Lewis BG, Koncikowski S. Laboratory Procedures Used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. 1996.
29. Daum P, Estergreen J, Wener.M. Laboratory Procedure Manual: Rate of Clot Formation on the STA-Compact. 2000.
30. Carlson CS, Eberle MA, Rieder MJ, et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004; 74: 106-120.
31. Crawford DC, Akey DT, Nickerson DA. The patterns of natural variation in human genes. Annu Rev Genomics Hum Genet 2005; 6: 287-312.
32. Grady BJ, Torstenson E, Dudek SM, et al. Finding unique filter sets in plato: a precursor to efficient interaction analysis in gwas data. Pac Symp Biocomput 2010; 315-326.
33. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
34. Pendergrass SA, Dudek S, Crawford DCC, et al. Synthesis-View: visualization and interpretation of SNP association results for multi-cohort, multi-phenotype data and meta-analysis. BioData Mining 2010; 3: 10.
35. Reiner AP, Carty CL, Carlson CS, et al. Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study. J Thromb Haemost 2006; 4: 1279-1287.
36. Wassel CL, Lange LA, Keating BJ, et al. Association of genomic loci from a cardiovascular gene SNP array with fibrinogen levels in European Americans and African-Americans from six cohort studies: the Candidate gene Association Resource (CARe). Blood 2011; 117: 268-275.
37. Dehghan A, Yang Q, Peters A, et al. Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts. Circ Cardiovasc Genet 2009; 2: 125-133.
38. Kottke-Marchant K. Genetic polymorphisms associated with venous and arterial thrombosis: an overview. Arch Pathol Lab Med 2011; 126: 295-304.
39. Wagner GP, Zhang J. The pleiotropic structure of the genotype-phenotype map: the evolvability of complex organisms. Nat Rev Genet 2011; 12: 204-213.
40. Pendergrass SA, Brown-Gentry K, Dudek SM, et al. The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery. Genet Epidemiol 2011; 35: 410-422.
41. David Ginsburg. Genetic Risk Factors for Arterial Thrombosis and Inflammation. Hematology 2005; 442-444.
42. Feinbloom D, Bauer KA. Assessment of hemostatic risk factors in predicting arterial thrombotic events. Arterioscler Thromb Vasc Biol 2005; 25: 2043-2053.
43. Lane DA, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000; 95: 1517-1532.
44. Lowe GD. Common risk factors for both arterial and venous thrombosis. Br J Haematol 2008; 140: 488-495.
45. Mackman N. Triggers, targets and treatments for thrombosis. Nature 2008; 451: 914-918.